Literature DB >> 6726285

Low energy levels in thiamine-deficient encephalopathy.

H Aikawa, I S Watanabe, T Furuse, Y Iwasaki, E Satoyoshi, T Sumi, T Moroji.   

Abstract

Pyrithiamine-induced acute thiamine-deficient encephalopathy was produced in adult male Wistar rats. Twenty-four hours before the onset of neurological signs the brain showed no morphological abnormalities. Encephalopathic rats had symmetrical lesions of edematous necrosis localized in the thalamus, mammillary body, and pontine tegmentum. Biochemically, encephalopathic rats had brain thiamine levels less than 20% of controls. For the assay of the concentrations of adenosine triphosphate (ATP) and phosphocreatine, the brains were fixed using 5 KW microwave irradiation and were divided into four parts: cerebral cortex, diencephalon, lower brainstem, and cerebellum. In the lower brainstem of the encephalopathic rats ATP concentrations were 89.5% of normal controls. Phosphocreatine levels were lowered to 70% of controls in the diencephalon and to 75% in the lower brainstem. Total high energy phosphate levels were decreased to 89% of controls in the diencephalon and 91% in the lower brainstem before the onset of neurological signs and to 76% and 79%, respectively, after the onset. In the cerebral cortex and cerebellum high energy phosphates were not significantly reduced. Lower high energy phosphate levels and the distribution of edematous lesions were coincident in the brain. These findings suggest that a low energy state is closely related to the formation of edematous lesions in thiamine-deficient encephalopathy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6726285     DOI: 10.1097/00005072-198405000-00006

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  37 in total

1.  Immediate-early gene expression in the brain of the thiamine-deficient rat.

Authors:  A S Hazell; L McGahan; W Tetzlaff; A M Bedard; G S Robertson; Y Nakabeppu; A M Hakim
Journal:  J Mol Neurosci       Date:  1998-02       Impact factor: 3.444

2.  Mechanisms of cell death in cholinergic basal forebrain neurons in chronic alcoholics.

Authors:  K M Cullen; G M Halliday
Journal:  Metab Brain Dis       Date:  1995-03       Impact factor: 3.584

Review 3.  The blood-brain barrier and selective vulnerability in experimental thiamine-deficiency encephalopathy in the mouse.

Authors:  N Harata; Y Iwasaki
Journal:  Metab Brain Dis       Date:  1996-03       Impact factor: 3.584

Review 4.  Mechanisms of neuronal cell death in Wernicke's encephalopathy.

Authors:  A S Hazell; K G Todd; R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-06       Impact factor: 3.584

Review 5.  Pathophysiology of alcoholic brain damage: synergistic effects of ethanol, thiamine deficiency and alcoholic liver disease.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  1995-03       Impact factor: 3.584

Review 6.  Pathogenesis of diencephalic lesions in an experimental model of Wernicke's encephalopathy.

Authors:  P J Langlais
Journal:  Metab Brain Dis       Date:  1995-03       Impact factor: 3.584

7.  Reappraisal of regional thiamine content in the central nervous system of the normal and thiamine-deficient mice.

Authors:  N Harata; Y Iwasaki; Y Ohara
Journal:  Metab Brain Dis       Date:  1993-03       Impact factor: 3.584

Review 8.  Neuronal cell death in Wernicke's encephalopathy: pathophysiologic mechanisms and implications for PET imaging.

Authors:  D K Leong; R F Butterworth
Journal:  Metab Brain Dis       Date:  1996-03       Impact factor: 3.584

Review 9.  Alterations of thiamine phosphorylation and of thiamine-dependent enzymes in Alzheimer's disease.

Authors:  M Héroux; V L Raghavendra Rao; J Lavoie; J S Richardson; R F Butterworth
Journal:  Metab Brain Dis       Date:  1996-03       Impact factor: 3.584

10.  Activities of thiamine-dependent enzymes in two experimental models of thiamine-deficiency encephalopathy: 1. The pyruvate dehydrogenase complex.

Authors:  R F Butterworth; J F Giguere; A M Besnard
Journal:  Neurochem Res       Date:  1985-10       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.